Invitrogen™ Cytomegalovirus p65 Monoclonal Antibody (CMV-224)

Catalog No.	Quantity
PIMA533319	100 μg

Catalog No. PIMA533319

Supplier: Invitrogen™ MA533319

Description

Mouse Monoclonal Antibody

Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Specifications

• Antigen: Cytomegalovirus p65
• Applications: ELISA, Flow Cytometry, Immunohistochemistry (Frozen)
• Classification: Monoclonal
• Clone: CMV-224
• Concentration: 100 μg/mL
• Conjugate: Unconjugated
• Formulation: PBS with 0.02% sodium azide
• Gene Alias: CMV; CMV p65
• Host Species: Mouse
• Immunogen: Recombinant CMV-p65 protein.
• Purification Method: Protein A/G
• Quantity: 100 μg
• Regulatory Status: RUO
• Primary or Secondary: Primary
• Target Species: Virus
• Content And Storage: 4°C, do not freeze
• Product Type: Antibody
• Form: Liquid
• Isotype: IgG1 κ